Literature DB >> 3029314

Effects of the epipodophyllotoxin VP-16-213 on herpes simplex virus type 2 replication.

Y Nishiyama, H Fujioka, T Tsurumi, N Yamamoto, K Maeno, S Yoshida, K Shimokata.   

Abstract

It has been recently shown that VP-16-213, a semi-synthetic derivative of podophyllotoxin, inhibits the function of mammalian DNA topoisomerase II. In the present study, we examined the effects of VP-16-213 on the replication of herpes simplex virus type 2 (HSV-2). The compound did not inhibit the synthesis of early viral polypeptides at concentrations at which viral DNA synthesis was strongly suppressed, but induced double-strand breaks in newly synthesized HSV DNA. Electron microscopic examination of treated cells revealed the presence of a number of capsids with empty or partial cores. The level of topoisomerase II activity remained unaltered after infection, and all attempts to isolate VP-16-213-resistant mutants of HSV-2 have failed in spite of extensive efforts. It is suggested therefore that the mode of action of VP-16-213 may be inhibition of viral DNA synthesis by impairing the function of host cell topoisomerase II.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029314     DOI: 10.1099/0022-1317-68-3-913

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

1.  Topoisomerase II cleavage of herpes simplex virus type 1 DNA in vivo is replication dependent.

Authors:  S N Ebert; S S Shtrom; M T Muller
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

2.  Role of DNA topoisomerase I in the replication of herpes simplex virus type 2.

Authors:  Y Yamada; N Yamamoto; K Maeno; Y Nishiyama
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Inhibition of herpes simplex virus replication by genistein, an inhibitor of protein-tyrosine kinase.

Authors:  Y Yura; H Yoshida; M Sato
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Lack of in vitro antiviral activity of fluoroquinolones against herpes simplex virus type 2.

Authors:  A Pessina; E Mineo; L Gribaldo; M G Neri
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  An etoposide-induced block in vaccinia virus telomere resolution is dependent on the virus-encoded DNA ligase.

Authors:  A M DeLange; M S Carpenter; J Choy; V E Newsway
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

6.  Establishment and characterization of resistant cells to etoposide (VP16) from a mouse breast cancer cell line, FM3A.

Authors:  E Takagi; H Kawatsu; K Shimokata; Y Nishiyama; K Kojima; S Yoshida
Journal:  Jpn J Cancer Res       Date:  1988-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.